EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Mechanism Study of Ginsenoside Rd in the Prevention and Treatment of Post-Myocardial Infarction Heart Failure: Network Pharmacology Combined with in vivo and in vitro Experiments Verification

Tingyao Zhao, Huili Liao, Rongfei Wang, Bodi Xiao, Zhaocong Li, Fangyuan Qu, Minqi Lu, Zhongqi Yang, Shihao Ni, Xinting Wang iD

Drug Design, Development and Therapy · 2026

DOI: 10.2147/dddt.s651891 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2026. Verfasst von Tingyao Zhao und 9 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Traditional Chinese Medicine Syndrome, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, …. Hauptthemen laut MEDLINE: Ginsenosides, Myocardial Infarction, Heart Failure. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GinsenosidesMyocardial InfarctionHeart FailureAnimalsMiceMaleRAW 264.7 CellsNetwork PharmacologyMice, Inbred C57BLT-Lymphocytes, RegulatoryMolecular Docking SimulationMacrophagesPanaxInterleukin-10Disease Models, Animal

Stichwörter der Autor:innen

Panax ginseng C.A. Meyginsenoside Rdmonocytes/macrophagespost-myocardial infarction heart failureregulatory T cells

Substanzen

Ginsenosidesginsenoside RdInterleukin-10

Autor:innen und Institutionen

  • State Key Laboratory of Traditional Chinese Medicine Syndrome, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, People's Republic of China.
  • Department of Geriatrics, The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou, 510405, People's Republic of China.
  • Key Laboratory of Traditional Chinese Medicine Prevention and Treatment of Chronic Heart Failure, Guangdong Clinical Research Institute of Traditional Chinese Medicine, Guangzhou, 510405, People's Republic of China.

ORCID-Profile: Xinting Wang

Zitieren

APA

Zhao, T., Liao, H., Wang, R., Xiao, B., Li, Z., Qu, F., Lu, M., Yang, Z., Ni, S., & Wang, X. (2026). Mechanism Study of Ginsenoside Rd in the Prevention and Treatment of Post-Myocardial Infarction Heart Failure: Network Pharmacology Combined with in vivo and in vitro Experiments Verification. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s651891

Vancouver

Zhao T, Liao H, Wang R, Xiao B, Li Z, Qu F, et al. Mechanism Study of Ginsenoside Rd in the Prevention and Treatment of Post-Myocardial Infarction Heart Failure: Network Pharmacology Combined with in vivo and in vitro Experiments Verification. Drug Design, Development and Therapy. 2026. doi:10.2147/dddt.s651891

BibTeX
@article{Zhao2026,
  author = {Zhao, Tingyao and Liao, Huili and Wang, Rongfei and Xiao, Bodi and Li, Zhaocong and Qu, Fangyuan and Lu, Minqi and Yang, Zhongqi and Ni, Shihao and Wang, Xinting},
  title = {Mechanism Study of Ginsenoside Rd in the Prevention and Treatment of Post-Myocardial Infarction Heart Failure: Network Pharmacology Combined with in vivo and in vitro Experiments Verification},
  journal = {Drug Design, Development and Therapy},
  year = {2026},
  doi = {10.2147/dddt.s651891}
}
Kostenlos starten →